{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-064675","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.726694+00:00","generated_at":"2026-06-01T09:15:34.971768+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"NRx Pharmaceuticals underwriters exercise overallotment, purchase 91,050 shares at $3.30","bullets":["Underwriters exercised option to buy 91,050 additional shares at $3.30 per share from previously announced offering.","Gross proceeds from overallotment approximately $300,465; closed May 23, 2024.","Overallotment exercise completed; shares issued at same price as initial public offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-064675","json":"https://secwatch.observer/filing/0001104659-24-064675.json","markdown":"https://secwatch.observer/filing/0001104659-24-064675.md","text":"https://secwatch.observer/filing/0001104659-24-064675.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000110465924064675/0001104659-24-064675-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000110465924064675/tm2415394d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:15:34.971768+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}